Fundamental Analysis
65 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1325.5% | +318.4% | 1 / 3 | +125.0% | -7.53 pp | +7.10 pp | +13.2% | 1.16 | 5.68 | 154 | +125,0% | 12,9 | +1.325,5% | 5.68 | 24.73 | −77,0% |
| Pts | 12 | 12 | 4 | 12 | 0 | 12 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 10.200 (close price on 2026-10-19)EPS (TTM): 1.796
Financial charts
1.Revenue & growth
VND bn154Q2/26
1.Revenue & growth
VND bn154Q2/26
2.Profit & growth
VND bn12,9Q2/26
3.Profit mix (Penman)
VND bn19,8Q2/26
4.Margins & cost structure
%7.2%Q2/26
5.Returns & cash cycle
% · days6.3%Q2/26
6.Earnings quality & cash
VND bn-47,5Q2/26
7.Asset structure
VND bn531Q2/26
8.Funding & debt health
VND bn · times531Q2/26
9.Revenue backlog
VND bn196Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.627Q2/26
Adjusted EPS growth, latest quarter
14,3× higher
Average adjusted EPS growth, 3 quarters
619%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26